Abstract View

Author(s): Khan Ramiz Viquar*1, Vaibhavi Santosh Dhangar2, Nikita Ravindra Pagare3, Koli Punam Suresh4, Pranjal Komalsing Girase5

Email(s): 1khanramiz313@gmail.com

Address:

    Department of pharmaceutics Dadasaheb Rawal Pharmacy College Dondaicha

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5602  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Withania somnifera (L.) Dunal, commonly known as Ashwagandha or Indian ginseng, is one of the most important medicinal plants used in traditional Ayurvedic medicine for more than 3000 years. It has historically been employed as a rejuvenating tonic (Rasayana) to enhance vitality, promote longevity, and improve resistance to stress. In recent years, scientific interest in Ashwagandha has increased considerably because of its broad spectrum of pharmacological activities and potential therapeutic applications. Various preclinical and clinical studies have demonstrated that Ashwagandha possesses adaptogenic, antioxidant, anti-inflammatory, antimicrobial, immunomodulatory, neuroprotective, cardio protective, antidiabetic, and reproductive health-promoting properties. These biological activities are mainly attributed to the presence of bioactive constituents such as withanolides, alkaloids, flavonoids, and other phytochemicals. Furthermore, growing evidence suggests its beneficial role in managing stress, anxiety, sleep disorders, cognitive impairment, chronic fatigue, thyroid dysfunction, and enhancement of physical performance. Despite promising outcomes, current evidence remains limited by methodological heterogeneity, variations in dosage regimens, extract standardization, study duration, and relatively small sample sizes. This review aims to provide a comprehensive overview of the Phytochemistry, pharmacological activities, therapeutic potential, and possible mechanisms of action of Withania somnifera, while critically evaluating current scientific evidence and highlighting existing limitations.

Cite this article:
Khan Ramiz Viquar, Vaibhavi Santosh Dhangar, Nikita Ravindra Pagare, Koli Punam Suresh, Pranjal Komalsing Girase. Withania somnifera (Ashwagandha): An Updated Review. IJRPAS, June 2026; 5(6): 20-35.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5602


References not available.

Related Images:



Recent Images



Impaired Glucose Homeostasis During Clozapine Therapy in A Schizophrenic Patient: A Case Report
Development and Validation of an Eco-Friendly RP-HPLC Method for the Quantitative Estimation of Desidustat in Human Plasma
Personalized Pharmacotherapy in Obesity: Current Challenges, Emerging Therapeutic Algorithms, and Future Directions
Petrological Study on Sunstone: An Interdisciplinary Approach to Evaluate the Effect of Shodhana by Petrographic Thin Section Analysis
Gut Microbiota in Human Health And Disease: A Review of Therapeutic Opportunities.
Development and evaluation of Metformin Hydrochloride floating tablets using natural polymers with drug-polymer compatibility study by FTIR and analysis by UV spectrophotometer
Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method

Tags